Benefits
BPH Symptom Improvement
Multiple trials (Schneider 2004, Lopatkin 2005) show nettle root improves BPH symptoms vs placebo. Often combined with saw palmetto (Prostagutt forte® / PRO 160/120 — 160 mg saw palmetto + 120 mg nettle root) — major European phytotherapy product.
SHBG Binding (Free Testosterone Theoretical)
Nettle root lignans bind to sex hormone-binding globulin (SHBG) — theoretically displacing testosterone and increasing free (active) testosterone. Mechanism cited for testosterone-supportive marketing. Clinical translation modest.
5-Alpha-Reductase Inhibition (Modest)
Nettle root modestly inhibits 5-alpha-reductase — same enzyme targeted by finasteride; reduces DHT formation. Component of mechanism for BPH benefits.
Aromatase Inhibition (Modest)
Some evidence for modest aromatase inhibition — reducing testosterone-to-estrogen conversion. Relevant for some men's health applications.
Urinary Symptom Improvement
Beyond BPH, may help functional urinary symptoms — frequency, urgency, nocturia. Used in some traditions for general urinary support.
Mechanism of action
SHBG Binding
Nettle root lignans bind SHBG with significant affinity in vitro — theoretically displacing testosterone and increasing free testosterone. In vivo significance debated; protein binding alterations have complex pharmacokinetic effects.
5-Alpha-Reductase Modulation
Modestly inhibits 5-alpha-reductase, reducing DHT formation. Less potent than finasteride but contributes to BPH effects.
Anti-Inflammatory in Prostate Tissue
Reduces inflammation in prostatic tissue — relevant for BPH (which has inflammatory component) and chronic prostatitis.
UDA Lectin Effects
Urtica dioica agglutinin (UDA) is a lectin with multiple cellular effects including immune modulation. Significance in supplementation context unclear.
Clinical trials
RCT of nettle root + saw palmetto combination (PRO 160/120) vs placebo in 257 BPH patients for 24 weeks.
257 BPH patients.
Significant improvement in IPSS (International Prostate Symptom Score), urinary flow, residual urine vs placebo. Combined product limits attribution to nettle root alone. Established Prostagutt as evidence-based European BPH product.
RCT of nettle root extract alone vs placebo in 620 BPH patients for 6 months.
620 BPH patients.
Significant improvement in BPH symptoms, urinary flow, post-void residual vs placebo. Established standalone nettle root efficacy.